Search

Author/Creator Turkiewicz, Anthony

1. 4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis. Issue 1 (14th March 2018)

Authors:
van der Heijde, Désirée; Deodhar, Atul; FitzGerald, Oliver; Fleischmann, Roy; Gladman, Dafna; Gottlieb, Alice B; Hoepken, Bengt; Bauer, Lars; Irvin-Sellers, Oscar; Khraishi, Majed; Peterson, Luke; Turkiewicz, Anthony; Wollenhaupt, Jürgen; Mease, Philip J
Journal:
RMD open
Issue:
Volume 4:Issue 1(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. OP0110 IXEKIZUMAB IMPROVES SIGNS AND SYMPTOMS OF PSORIATIC ARTHRITIS IN PATIENTS WHO HAVE HAD INADEQUATE RESPONSE TO 1 OR 2 TUMOR NECROSIS FACTOR INHIBITORS. (June 2019)

Authors:
Bruce Kirkham, L; Sesin, Carlos; Sprabery, Aubrey Trevelin; Lin, Chen-Yen; Gellett, Amanda M.; Turkiewicz, Anthony
Journal:
Annals of the rheumatic diseases
Issue:
Volume 78(2019)Supplement 2
Page Start:
128
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗